Cleared Traditional

K093210 - AQUALASE CAPSULE WASH TIP

K093210 is an FDA 510(k) clearance for AQUALASE CAPSULE WASH TIP, manufactured by Alcon Manufacturing, Ltd.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 142-day FDA review.

K093210 · Alcon Manufacturing, Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
142d
Days
Class 2
Risk

K093210 is an FDA 510(k) clearance for the AQUALASE CAPSULE WASH TIP. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Alcon Manufacturing, Ltd. (Irvine, US). The FDA issued a Cleared decision on March 4, 2010 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Alcon Manufacturing, Ltd. devices

FDA 510(k) Submission Details - K093210

510(k) Number K093210 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 2009
Decision Date March 04, 2010
Days to Decision 142 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 110d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 153
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K093210.
CENTURION Vision System (Active SentryTM)
K161794 · Alcon Research, Ltd. · Apr 2017
CENTURION VISION SYSTEM
K121555 · Alcon Laboratories, Inc. · Dec 2012
STELLARIS PC VISION ENHANCEMENT SYSTEM
K101325 · Bausch & Lomb, Inc. · Aug 2010
ALCON ULTRACHOPPER
K091777 · Alcon Research, Ltd. · Oct 2009
INFINITI VISION SYSTEM WITH OZIL IP
K082845 · Alcon Research, Ltd. · Feb 2009
BAUSCH & LOMB STELLARIS MICROSURGICAL SYSTEM
K082473 · Bausch & Lomb, Inc. · Jan 2009